Selected article for: "acute coronavirus syndrome and lung failure"

Author: Monteil, Vanessa; Kwon, Hyesoo; Prado, Patricia; Hagelkrüys, Astrid; Wimmer, Reiner A.; Stahl, Martin; Leopoldi, Alexandra; Garreta, Elena; Hurtado del Pozo, Carmen; Prosper, Felipe; Romero, Juan Pablo; Wirnsberger, Gerald; Zhang, Haibo; Slutsky, Arthur S.; Conder, Ryan; Montserrat, Nuria; Mirazimi, Ali; Penninger, Josef M.
Title: Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
  • Cord-id: 6fbftzk0
  • Document date: 2020_4_24
  • ID: 6fbftzk0
    Snippet: Summary We have previously provided the first genetic evidence that angiotensin converting enzyme 2 (ACE2) is the critical receptor for severe acute respiratory syndrome coronavirus (SARS-CoV), and ACE2 protects the lung from injury, providing a molecular explanation for the severe lung failure and death due to SARS-CoV infections. ACE2 has now also been identified as a key receptor for SARS-CoV-2 infections, and it has been proposed that inhibiting this interaction might be used in treating pat
    Document: Summary We have previously provided the first genetic evidence that angiotensin converting enzyme 2 (ACE2) is the critical receptor for severe acute respiratory syndrome coronavirus (SARS-CoV), and ACE2 protects the lung from injury, providing a molecular explanation for the severe lung failure and death due to SARS-CoV infections. ACE2 has now also been identified as a key receptor for SARS-CoV-2 infections, and it has been proposed that inhibiting this interaction might be used in treating patients with COVID-19. However, it is not known whether human recombinant soluble ACE2 (hrsACE2) blocks growth of SARS-CoV-2. Here, we show that clinical grade hrsACE2 reduced SARS-CoV-2 recovery from Vero cells by a factor of 1,000–5,000. An equivalent mouse rsACE2 had no effect. We also show that SARS-CoV-2 can directly infect engineered human blood vessel organoids and human kidney organoids, which can be inhibited by hrsACE2. These data demonstrate that hrsACE2 can significantly block early stages of SARS-CoV-2 infections.

    Search related documents:
    Co phrase search for related documents
    • accession number and loss virus: 1
    • active replication and acute ards respiratory distress syndrome: 1, 2
    • active replication and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active replication and lung injury: 1
    • acute ards respiratory distress syndrome and additional day: 1, 2, 3
    • acute ards respiratory distress syndrome and loss virus: 1
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
    • acute ards respiratory distress syndrome and lung injury protect: 1, 2
    • acute ards respiratory distress syndrome and lung injury protection: 1
    • acute ards respiratory distress syndrome and lung limit: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute ards respiratory distress syndrome and lung protect: 1, 2, 3, 4, 5, 6, 7, 8
    • acute sars cov respiratory syndrome coronavirus and additional day: 1, 2, 3, 4, 5, 6, 7
    • acute sars cov respiratory syndrome coronavirus and loss virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute sars cov respiratory syndrome coronavirus and low level expression: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and luminal surface: 1, 2
    • acute sars cov respiratory syndrome coronavirus and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute sars cov respiratory syndrome coronavirus and lung injury protection: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and lung limit: 1, 2
    • acute sars cov respiratory syndrome coronavirus and lung organoid: 1, 2